September 29, 2024Open Access

The value of predicting neoadjuvant chemotherapy early efficacy in nasopharyngeal carcinoma based on amide proton transfer imaging and diffusion weighted imaging

Key Points

Key points are not available for this paper at this time.

Abstract

Early detection of nasopharyngeal carcinoma (NPC) patients who are not sensitive to neoadjuvant chemotherapy (NAC) can guard against overtreatment. This study aimed to evaluate the effectiveness of amide proton transfer (APT) imaging and diffusion-weighted imaging (DWI) in predicting the early response to NAC in patients with NPC.

Read Full Paperexternally

AIに質問

Bookmark

View Full Paper

Cite This Study

Zhang et al. (Sun,) studied this question.

synapsesocial.com/papers/68e57074b6db64358751169e https://doi.org/https://doi.org/10.21037/qims-24-188

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The use of diffusion-weighted magnetic resonance imaging and parametric response mapping for disease outcome prediction in nasopharyngeal carcinoma2025 · 1 citations
2Predictive Value of [18F]FDG PET/CT for Neoadjuvant Chemoradiotherapy Response in Nasopharyngeal Carcinoma2025 · 3 citations
3APT histogram parameters for Response Prediction of Neoadjuvant Chemotherapy in Rectal Cancer: A Prospective Study2024
4Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinoma2024 · 4 citations
5Interpretable multimodal MRI radiomics for predicting neoadjuvant chemotherapy response in nasopharyngeal carcinoma2025 · 2 citations

AIに質問

Bookmark

View Full Paper